SBBP
NASDAQ:SBBP
Strongbridge Biopharma plc
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.strongbridgebio.comipo date
Sep 10, 2015
Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product can...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus